HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Synthetics Stance In NDI Guidance Raises Red Flag For Industry

This article was originally published in The Tan Sheet

Executive Summary

FDA's draft guidance on new dietary ingredient notifications already is arousing fierce pushback from the supplement industry over what constitutes an NDI and which substances cannot be dietary ingredients at all.

You may also be interested in...



Herbalife Proposes FDA Use NDI Master Files To Reduce Notification Burden

Herbalife asks FDA to temper its position that every supplement product containing a new dietary ingredient require a full notification, instead proposing a streamlined process based around NDI master files.

CHPA Urges Nuanced, Risk-Based Approach To Nanotechnology

FDA should not use size alone to regulate nanotechnology, the Consumer Healthcare Products Association says.

FDA Errs On Estimates For NDIs, Claims Substantiation – CRN

FDA “grossly underestimated” firms’ costs for filing new dietary ingredient notifications and ignored their costs for substantiating claims, the Council for Responsible Nutrition says in July 25 comments.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS134003

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel